- Home
- NKTR vs OBE Comparison
NKTR vs OBE Comparison
Compare NKTR & OBE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTR
- OBE
- Stock Information
- Founded
- NKTR 1990
- OBE 1979
- Country
- NKTR United States
- OBE Canada
- Employees
- NKTR N/A
- OBE N/A
- Industry
- NKTR Biotechnology: Pharmaceutical Preparations
- OBE Oil & Gas Production
- Sector
- NKTR Health Care
- OBE Energy
- Exchange
- NKTR Nasdaq
- OBE Nasdaq
- Market Cap
- NKTR 508.2M
- OBE 411.1M
- IPO Year
- NKTR 1994
- OBE N/A
- Fundamental
- Price
- NKTR $29.86
- OBE $6.17
- Analyst Decision
- NKTR Strong Buy
- OBE Buy
- Analyst Count
- NKTR 6
- OBE 2
- Target Price
- NKTR $81.67
- OBE $11.50
- AVG Volume (30 Days)
- NKTR 642.1K
- OBE 218.7K
- Earning Date
- NKTR 08-07-2025
- OBE 07-30-2025
- Dividend Yield
- NKTR N/A
- OBE N/A
- EPS Growth
- NKTR N/A
- OBE N/A
- EPS
- NKTR N/A
- OBE N/A
- Revenue
- NKTR $74,934,000.00
- OBE $508,849,882.00
- Revenue This Year
- NKTR N/A
- OBE N/A
- Revenue Next Year
- NKTR N/A
- OBE N/A
- P/E Ratio
- NKTR N/A
- OBE N/A
- Revenue Growth
- NKTR N/A
- OBE 1.49
- 52 Week Low
- NKTR $6.48
- OBE $3.88
- 52 Week High
- NKTR $37.38
- OBE $7.27
- Technical
- Relative Strength Index (RSI)
- NKTR 69.93
- OBE 60.61
- Support Level
- NKTR $26.45
- OBE $5.95
- Resistance Level
- NKTR $29.70
- OBE $6.31
- Average True Range (ATR)
- NKTR 1.69
- OBE 0.16
- MACD
- NKTR 0.27
- OBE 0.05
- Stochastic Oscillator
- NKTR 99.19
- OBE 81.65
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.
About OBE Obsidian Energy Ltd.
Obsidian Energy Ltd is an intermediate-sized oil and gas producer with strategic assets in Alberta. It operates in a single reporting segment that is exploration, development, and holding an interest in oil and natural gas properties and related production infrastructure in the Western Canada Sedimentary Basin. The company generates the majority of the revenue from the Crude oil sale.